aibio
Debt Financing ·
Imugene amends CVI convertible notes and issues new warrants
A$2.1 million of existing notes is redeemed and replaced by new zero-coupon notes, and the remaining notes amortise in five instalments.
IMU Imugene Ltd
Imugene (IMU) news IMU convertible notes news
Latest Imugene news
We have not published a story on Imugene yet. When there is news, it will appear here.
Questions about Imugene
Has Imugene sold convertible notes?
Our latest story on this, dated Aug 21, 2026: "Imugene amends CVI convertible notes and issues new warrants". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Imugene?
Imugene Ltd trades under the ticker IMU on ASX.
Where is Imugene listed?
Imugene Ltd is listed on ASX. Our directory also records these other listings: OTC:IUGNF.
Which country or territory is Imugene listed under?
Our directory records Imugene Ltd under Australia.
What does Imugene do?
Our directory classifies Imugene Ltd as: Biotechnology. This is a directory classification, not a description of the pipeline.
What is the ISIN of Imugene?
The ISIN recorded for Imugene Ltd is AU000000IMU9.
Does aibio.space cover Imugene?
aibio.space lists Imugene Ltd among 2,820 public biotech companies and publishes its news here as stories appear.
What is the latest Imugene (IMU) stock news?
Our latest story on Imugene, dated Aug 21, 2026: "Imugene amends CVI convertible notes and issues new warrants". A$2.1 million of existing notes is redeemed and replaced by new zero-coupon notes, and the remaining notes amortise in five instalments. Source.
Which companies are similar to Imugene?
Companies in our directory listed in the same country and business area as Imugene: Incannex Healthcare, Identifai Genetics, Invex Therapeutics, Neuroscientific Biopharmaceuticals, LTR Pharma, Biotron.
How can I follow Imugene (IMU) news?
Press Follow on this page to add Imugene to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Imugene so far, in Debt Financing.
Investor discussion: Imugene
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Stock chart
Listing details
- Company
- Imugene Ltd
- Ticker
- IMU
- Listing
- ASX
- Country or territory
- Australia
- Business scope
- Biotechnology
- ISIN
- AU000000IMU9
- Other listed symbols
- OTC:IUGNF
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction